Amgen Inc (AMGN)

Exchange: NASDAQ
Currency: USD

Price: 271.73 (Close)



52 Week range 200d Moving Avg. Beta
209.61 – 294.64 254.02 0.35
Dividend Dividend Yield Ex-Dividend date
7.68 2.83% 2022-11-16
P/E Ratio Latest EPS DGR 3 years
22.98 0.00 10.06%
Near Fair Value
Very low Volatility
Dividend Growth


Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company’s products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.


Sector: Industry:
Healthcare Drug Manufacturers—General

Environment, Social and Governance (ESG) Ratings

Total ESG Score

21 – 24 percentile


2 – 3 percentile


15 – 3 percentile


6 – 3 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 0.00
Annual Payout 7.68
Payout Ratio 0.00%
Dividend growth 0 Years
Dividend Score 0
Dividend Coverage Ratio 1.34
Altman-Z score 0.00


Amgen Inc (AMGN) Valuation

Amgen Inc’s current dividend yield of 2.83% is 4% just above its 5-year average. The 5-year average dividend yield is 2.74% (see red-line in chart). This indicates the stock looks reasonably valued today.

Amgen Inc (AMGN) Performance

The chart below displays the total price return(%) of Amgen Inc for different periods:


Amgen Inc (AMGN) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Amgen Inc for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
2.83 7.68 0.00% 0 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 10.06%
5 Year Growth Rate (CAGR) 11.97%
10 Year Growth Rate (CAGR) 28.81%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2022 3.880 -44.9%
2021 7.040 10.0%
2020 6.400 10.3%
2019 5.800 9.8%
2018 5.280 14.8%
2017 4.600 15.0%
2016 4.000 26.6%
2015 3.160 29.5%
2014 2.440 29.8%
2013 1.880 30.6%
2012 1.440 157.1%
2011 0.560 279,900.0%

Amgen Inc (AMGN) Dividend Payment History